An eight-miRNA signature expression-based risk scoring system for prediction of survival in pancreatic adenocarcinoma
Author:
Affiliation:
1. Radiotherapy Department of Shenzhen Baoan People’s Hospital, Shenzhen 518101, Guangdong, China
2. Oncology Department of ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, Guangdong, China
Publisher
IOS Press
Subject
Cancer Research,Genetics,Oncology,General Medicine
Reference36 articles.
1. Cancer statistics, 2016;Siegel;Ca A Cancer Journal for Clinicians,2016
2. B. Stewart and C. Wild, World Cancer Report 2014, International Agency for Research on Cancer, 2014.
3. Pancreatic adenocarcinoma;Bondsmith;BMJ,2012
4. Circulating miRNAs: Roles in cancer diagnosis, prognosis and therapy;Cheng;Advanced Drug Delivery Reviews,2015
5. miRNAs, cancer, and stem cell division;Croce;Cell,2005
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A 70‑RNA model based on SVR and RFE for predicting the pancreatic cancer clinical prognosis;Methods;2022-08
2. Scoring systems for the management of oncological hepato-pancreato-biliary patients;Annals of Hepato-Biliary-Pancreatic Surgery;2022-02-28
3. Establishment of a 4-miRNA Prognostic Model for Risk Stratification of Patients With Pancreatic Adenocarcinoma;Frontiers in Oncology;2022-02-03
4. MicroRNA-496 inhibits triple negative breast cancer cell proliferation by targeting Del-1;Medicine;2021-04-09
5. miR‑1301‑3p promotes the proliferation and migration of lung cancer cells via direct repression of polymerase I and transcript release factor;Oncology Letters;2020-09-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3